1. Home
  2. SATL vs GHRS Comparison

SATL vs GHRS Comparison

Compare SATL & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellogic Inc.

SATL

Satellogic Inc.

HOLD

Current Price

$10.44

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$22.47

Market Cap

947.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SATL
GHRS
Founded
2010
2018
Country
United States
Ireland
Employees
154
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
947.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SATL
GHRS
Price
$10.44
$22.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$5.50
$41.38
AVG Volume (30 Days)
7.4M
193.2K
Earning Date
05-12-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$88.89
N/A
Revenue Next Year
$56.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$10.96
52 Week High
$10.19
$24.66

Technical Indicators

Market Signals
Indicator
SATL
GHRS
Relative Strength Index (RSI) 70.43 61.36
Support Level $3.18 $12.65
Resistance Level N/A $22.88
Average True Range (ATR) 0.96 1.49
MACD 0.20 -0.13
Stochastic Oscillator 96.80 58.59

Price Performance

Historical Comparison
SATL
GHRS

About SATL Satellogic Inc.

Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: